Related Experiment Video

Updated: Dec 8, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K

Neuro-oncology tracers: an already limited supply impacted by the pandemic?

Yazeed Aldalilah1,2, Francesco Fraioli1, Jamshed Bomanji1

  • 1University College London Hospital NHS Trust, Institute of Nuclear Medicine, London, UK.

Nuclear Medicine Communications
|September 21, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

7.8K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.8K

Related Experiment Videos

Last Updated: Dec 8, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

7.8K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.8K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.7K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

360
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
360

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy, safety, and quality of life outcomes of [177Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.

International urology and nephrology·2026

An FDG-first functional imaging approach in phaeochromocytoma and paraganglioma.

Frontiers in endocrinology·2026

Pulmonary [18F]FDG uptake demonstrates phenotypic PET behaviour in non-specific interstitial pneumonitis and refines risk stratification.

European journal of nuclear medicine and molecular imaging·2026

Real-world evaluation of large language model for patients medical and administrative queries in nuclear medicine.

NPJ digital medicine·2026

From 18 F-choline to prostate-specific membrane antigen PET: lessons from early multiparametric kinetic modelling in prostate cancer.

Nuclear medicine communications·2026

18 F choline PET/MR to assess clinically significant disease in prostate cancer: Correlation with maximum and total cancer core length obtained via template mapping biopsies.

Nuclear medicine communications·2026

Hepatic reticuloendothelial distribution on sulfur colloid single-photon emission computed tomography/computed tomography is discordant with biochemical liver function in patients undergoing preradioembolization evaluation.

Nuclear medicine communications·2026

Comprehensive acceptance testing and quality control of Single Photon Emission Computed Tomography/Computed Tomography systems.

Nuclear medicine communications·2026

Fluorodeoxyglucose PET/CT-derived Metabolic Peritoneal Cancer Index for survival assessment in peritoneal carcinomatosis.

Nuclear medicine communications·2026

Predictive value of metabolic and tumor dissemination parameters in diffuse large B-cell lymphoma: can relapse be predicted despite adequate interim PET response?

Nuclear medicine communications·2026

Prognostic impact of risk organ involvement and metabolic parameters assessed by staging 18F-FDG PET/CT in pediatric Langerhans cell histiocytosis.

Nuclear medicine communications·2026

The utility of 18F-fluorodeoxyglucose PET/computed tomography in relapsing polychondritis: a systematic review and meta-analysis.

Nuclear medicine communications·2026

KRAS-mutated endometrial carcinomas: a comprehensive analysis of clinicopathological and molecular profiles across histological subtypes.

Virchows Archiv : an international journal of pathology·2026

Mesenchymal Tumors Feature a Spatially Defined Glial-Tip Cell Niche Around the Tumor Boundary in Microsatellite-Stable Colorectal Cancer.

Cancer research·2026

Integrated Genomic Profiling of PTEN and TP53 in Cervical Neuroendocrine Carcinoma: Synergistic Roles With HER2/KRAS/PIK3CA and Implications for Precision Oncology.

Genes, chromosomes & cancer·2026

Discrepancies in low-value practices across cardiovascular disease prevention guidelines. A narrative review.

The European journal of general practice·2026

The Impact of the COVID-19 Pandemic on Childhood Cancer Survival: A Population-Based Assessment of Survival Patterns Between 2015 and 2023 in Germany.

Pediatric blood & cancer·2026

Metastatic niche shaped by host factors influences disseminated cancer cell fate.

FEBS letters·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us